Press Release (ePRNews.com) - DENVER - Nov 15, 2019 - Redwood Green Corp. (“Redwood Green”) (OTC:RDGC), a leading U.S. provider of high-quality, safe, sustainable, innovative and accessible cannabis products, announces that the Company’s OTC ticker symbol has been updated to RDGC (previously FCOL). Trading under the new ticker symbol will begin at the opening of the market on November 15. This new ticker symbol more accurately aligns with the Company’s new name, announced Sept. 20, 2019. In addition, a new CUSIP number, 75806L101, has been assigned to the Company’s common stock.
“We are pleased to begin trading under our new ticker symbol as we complete the final ‘housekeeping’ tasks associated with our 2019 change in name and strategy,” stated Redwood Green Corp. CEO Christopher Hansen. “These foundational building blocks have been set in place even as we have continued to move forward operationally with development of our previous acquisitions and diligent consideration of potential future opportunities, with an eye on near-term revenue generation, as well as long-term growth opportunities.”
“The Company will have a presence at MJBizCon Las Vegas in December, the annual national investor conference and industry expo, as we further explore and grow our industry relationships, as well as customer and partnership prospects. More details about our attendance will be forthcoming as we get closer in time to the event. We also look forward to sharing updates on exciting operational developments for Redwood Green Corp.’s subsidiaries in the coming weeks.”
About Redwood Green Corp.
Redwood Green delivers high-quality, safe, sustainable, innovative and accessible cannabis products that support individual well-being. Safe, high-quality products for our own brands, as well as for the partners that we do business with, is a critical commitment from Redwood Green. The drive behind what we do is rooted in improving well-being and the quality of life for a wide range of audiences, ensuring we grow and improve upon what is currently available in the CBD market for consumers. The company is publicly traded and listed on the OTC (symbol: RDGC).
This press release is not an offer of securities, or a solicitation for purchase, subscription or sale of securities in the United States of America or in any other jurisdiction in which it would be unlawful to do so.
For more information:
This press release message may contain forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as demand for the Company’s products, internal funding and the financial condition of the Company, product roll-out, competition, technological changes, and other commercial matters involving the Company, its products and the markets in which the Company operates, as well as general economic conditions, which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this email message. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in subsequent reports should be consulted.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable U.S. federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve Redwood Green of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against Redwood Green. Enforcement of federal laws in the United States remains a significant risk to the business of Redwood Green and any proceedings brought against Redwood Green thereunder may adversely affect the Company’s operations and financial performance.
Redwood Green Corp.